1. AB0089 The association of interleukin 23 concentration with clinical course of systemic lupus erythematosus. (23rd January 2014) Authors: Fischer, K.M.; Przepiera-Będzak, H.; Fliciński, J.; Walecka, A.; Sawicki, M.; Ostanek, L.; Brzosko, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0174 Relationship of matrix metalloproteinase-3 concentration with clinical, laboratory and ultrasonographic markers of rheumatoid arthritis activity. (23rd January 2014) Authors: Flicinski, J.; Kubis, M.; Brzezinski, M.; Kaszuba, M.; Butkiewicz, F.; Izbicki, J.; Lopinski, H.; Fischer, K.; Brzosko, M. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A838 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0790 Impairment of the left ventricle (LV) and right ventricle (RV) of the heart in patients with systemic sclerosis and their association with level of interleukin 6 (IL-6) and n-terminal prohormone of brain natriuretic peptide (NT-PROBNP) – own experiences. (23rd January 2014) Authors: Trzcinska-Butkiewicz, B.; Peregud-Pogorzelska, M.; Wόdecki, M.; Brzosko, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 683 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0791 Risk factors of death of patients with systemic sclerosis (SS) – own observations. (23rd January 2014) Authors: Trzcinska-Butkiewicz, B.; Peregud-Pogorzelska, M.; Wόdecki, M.; Brzosko, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 683 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0932 Sapho syndrome - comparison of different methods of imaging of sterno-clavicular joints. (23rd January 2014) Authors: Przepiera-Bedzak, H.; Cyrylowski, L.; Brzosko, I.; Brzosko, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 692 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0223 SUBPHENOTYPES OF ANCA ASSOCIATED VASCULITIS IDENTIFIED BY LATENT CLASS ANALYSIS. (13th June 2020) Authors: Wójcik, K.; Ćmiel, A.; Masiak, A.; Zdrojewski, Z.; Jeleniewicz, R.; Majdan, M.; Brzosko, I.; Brzosko, M.; Głuszko, P.; Stasiek, M.; Wisłowska, M.; Kur-Zalewska, J.; Madej, M.; Hawrot-Kawecka, A.; Storoniak, H.; Bułło-Piontecka, B.; Dębska-Ślizień, A.; Kucharz, E.; Jakuszko, K.; Musiał, J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OP0090 Serum CD163/Tweak Ratio Predicts Clinical Course of Digital Ulcers in Patients with Systemic Sclerosis. (10th June 2014) Authors: Kowal-Bielecka, O.; Bielecki, M.; Trzcinska-Butkiewicz, B.; Michalska-Jakubus, M.; Brzosko, M.; Krasowska, D.; Kowal, K. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OP0157 Clinical Response of Disease Activity, Disability and Mobility Indices in Relation to Anti-Drug Antibody in the Planetas. (10th June 2014) Authors: Park, W.; Yoo, D.H.; Szántό, S.; Berghea, F.; Brzosko, M.; Wiland, P.; Smiyan, S.; Araiza-Casillas, R.; Díaz-González, F.; Suh, J.H. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SAT0103 Lithe: Tocilizumab (TCZ) Inhibits Radiographic Progression and Improves Physical Function in Patients (PTS) With Rheumatoid Arthritis (RA) at 5 Years With Maintenance of Clinical Efficacy Over Time. (23rd January 2014) Authors: Kremer, J.; Halland, A.-M.; Brzosko, M.; Burgos-Vargas, R.; Mela, C.; Vernon, E.; Fleischmann, R. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A614 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SAT0265 RISK FACTORS FOR INFECTIOUS COMPLICATIONS FOLLOWING RITUXIMAB TREATMENT – MULTICENTER POLISH EXPERIENCE. (2nd June 2020) Authors: Masiak, A.; Ziętkiewicz, M.; Wójcik, K.; Wawrzycka-Adamczyk, K.; Madej, M.; Kur-Zalewska, J.; Wisłowska, M.; Storoniak, H.; Komorniczak, M.; Brzosko, I.; Brzosko, M.; Dębska-Ślizień, A.; Musiał, J.; Zdrojewski, Z. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1076 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗